Michael Raab insider trades
Michael Raab has filed 72 Form 4s with the SEC that we hold, for Ardelyx, INC. (ARDX) (President & CEO, Director), FOLD (Director) and Tempest Therapeutics, Inc. (TPST) (Director). Across all of them we count 1 purchase worth $1.9K and 67 sales worth $6.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 19 sales ($2.6M). The largest single trade was a sale of 45,687 shares of Ardelyx, INC. worth $270.9K, dated 2025-08-21. Of 4 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-05 and the latest 2026-08-25.
Ardelyx, INC. (ARDX)
President & CEO, Director · 59 filings · 66 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-08-20 | S, sale reported on Form 4 | 2,573 | $3.4K | 2021-08-24 | SEC |
| 2021-11-22 | S, sale reported on Form 4 | 2,607 | $2.6K | 2021-11-24 | SEC |
| 2022-02-22 | S, sale reported on Form 4 | 6,229 | $4.2K | 2022-02-25 | SEC |
| 2022-05-20 | S, sale reported on Form 4 | 6,124 | $4.1K | 2022-05-23 | SEC |
| 2022-06-06 | S, sale reported on Form 4 | 101,480 | $66.0K | 2022-06-08 | SEC |
| 2022-06-06 | S, sale reported on Form 4 | 2,144 | $1.4K | 2022-06-08 | SEC |
| 2022-08-22 | S, sale reported on Form 4 | 76 | $74 | 2022-08-24 | SEC |
| 2022-08-22 | S, sale reported on Form 4 | 54 | $53 | 2022-08-24 | SEC |
| 2022-08-22 | S, sale reported on Form 4 | 6,016 | $5.9K | 2022-08-24 | SEC |
| 2022-08-31 | P, purchase reported on Form 4 | 3,000 | $1.9K | 2022-09-01 | SEC |
| 2022-11-22 | S, sale reported on Form 4 | 121 | $235 | 2022-11-23 | SEC |
| 2022-11-22 | S, sale reported on Form 4 | 162 | $314 | 2022-11-23 | SEC |
| 2022-11-22 | S, sale reported on Form 4 | 5,936 | $11.6K | 2022-11-23 | SEC |
| 2023-02-21 | S, sale reported on Form 4 | 13,449 | $40.3K | 2023-02-24 | SEC |
| 2023-05-23 | S, sale reported on Form 4 | 11,357 | $41.5K | 2023-05-25 | SEC |
| 2023-08-21 | S, sale reported on Form 4 | 11,419 | $40.5K | 2023-08-23 | SEC |
| 2023-11-20 | S, sale reported on Form 4 | 11,368 | $49.6K | 2023-11-22 | SEC |
| 2024-02-20 | S, sale reported on Form 4 | 22,917 | $200.5K | 2024-02-22 | SEC |
| 2024-04-01 | S, sale reported on Form 4 | 1,518 | $11.1K | 2024-04-02 | SEC |
| 2024-04-15 | S, sale reported on Form 4 | 7,500 | $53.0K | 2024-04-17 | SEC |
| 2024-04-29 | S, sale reported on Form 4 | 30,000 | $192.0K | 2024-05-01 | SEC |
| 2024-05-14 | S, sale reported on Form 4 | 3,000 | $24.0K | 2024-05-15 | SEC |
| 2024-05-21 | S, sale reported on Form 4 | 31,484 | $245.9K | 2024-05-23 | SEC |
| 2024-05-29 | S, sale reported on Form 4 | 7,500 | $50.4K | 2024-05-31 | SEC |
| 2024-06-13 | S, sale reported on Form 4 | 35,000 | $232.8K | 2024-06-17 | SEC |
| 2024-06-28 | S, sale reported on Form 4 | 2,310 | $15.2K | 2024-06-28 | SEC |
| 2024-07-15 | S, sale reported on Form 4 | 7,500 | $44.8K | 2024-07-17 | SEC |
| 2024-07-29 | S, sale reported on Form 4 | 30,000 | $169.2K | 2024-07-31 | SEC |
| 2024-08-12 | S, sale reported on Form 4 | 1,229 | $7.0K | 2024-08-14 | SEC |
| 2024-08-20 | S, sale reported on Form 4 | 32,225 | $188.8K | 2024-08-22 | SEC |
| 2024-08-27 | S, sale reported on Form 4 | 7,500 | $46.6K | 2024-08-28 | SEC |
| 2024-09-11 | S, sale reported on Form 4 | 35,000 | $196.3K | 2024-09-13 | SEC |
| 2024-09-26 | S, sale reported on Form 4 | 3,000 | $18.2K | 2024-09-27 | SEC |
| 2024-10-11 | S, sale reported on Form 4 | 7,500 | $45.1K | 2024-10-15 | SEC |
| 2024-10-28 | S, sale reported on Form 4 | 25,000 | $147.8K | 2024-10-31 | SEC |
| 2024-11-11 | S, sale reported on Form 4 | 2,743 | $13.4K | 2024-11-12 | SEC |
| 2024-11-20 | S, sale reported on Form 4 | 31,980 | $153.2K | 2024-11-22 | SEC |
| 2024-11-25 | S, sale reported on Form 4 | 25,000 | $134.5K | 2024-11-27 | SEC |
| 2024-12-10 | S, sale reported on Form 4 | 25,000 | $131.5K | 2024-12-12 | SEC |
| 2025-01-07 | S, sale reported on Form 4 | 41,666 | $221.2K | 2025-01-10 | SEC |
| 2025-01-31 | S, sale reported on Form 4 | 41,666 | $223.3K | 2025-01-31 | SEC |
| 2025-02-20 | S, sale reported on Form 4 | 22,964 | $129.1K | 2025-02-21 | SEC |
| 2025-03-07 | S, sale reported on Form 4 | 41,668 | $223.3K | 2025-03-07 | SEC |
| 2025-04-04 | S, sale reported on Form 4 | 41,666 | $191.2K | 2025-04-08 | SEC |
| 2025-05-02 | S, sale reported on Form 4 | 41,666 | $177.1K | 2025-05-05 | SEC |
| 2025-05-20 | S, sale reported on Form 4 | 46,817 | $191.0K | 2025-05-22 | SEC |
| 2025-08-21 | S, sale reported on Form 4 | 45,687 | $270.9K | 2025-08-25 | SEC |
| 2025-11-21 | S, sale reported on Form 4 | 46,887 | $259.8K | 2025-11-25 | SEC |
| 2026-02-20 | S, sale reported on Form 4 | 2 | $11 | 2026-02-23 | SEC |
| 2026-02-20 | S, sale reported on Form 4 | 40,401 | $237.2K | 2026-02-23 | SEC |
| 2026-02-20 | S, sale reported on Form 4 | 5,576 | $31.8K | 2026-02-23 | SEC |
| 2026-02-20 | S, sale reported on Form 4 | 1 | $6 | 2026-02-23 | SEC |
| 2026-02-24 | S, sale reported on Form 4 | 41,666 | $260.8K | 2026-02-25 | SEC |
| 2026-03-16 | S, sale reported on Form 4 | 41,666 | $243.3K | 2026-03-18 | SEC |
| 2026-04-15 | S, sale reported on Form 4 | 41,668 | $262.1K | 2026-04-17 | SEC |
| 2026-05-15 | S, sale reported on Form 4 | 41,666 | $261.7K | 2026-05-19 | SEC |
| 2026-05-21 | S, sale reported on Form 4 | 14,028 | $88.0K | 2026-05-22 | SEC |
| 2026-05-21 | S, sale reported on Form 4 | 17,926 | $112.4K | 2026-05-22 | SEC |
| 2026-05-21 | S, sale reported on Form 4 | 7,861 | $49.3K | 2026-05-22 | SEC |
| 2026-05-21 | S, sale reported on Form 4 | 14,933 | $93.6K | 2026-05-22 | SEC |
| 2026-06-15 | S, sale reported on Form 4 | 41,666 | $236.2K | 2026-06-17 | SEC |
| 2026-07-15 | S, sale reported on Form 4 | 41,668 | $210.9K | 2026-07-17 | SEC |
| 2026-08-21 | S, sale reported on Form 4 | 15,009 | $57.9K | 2026-08-25 | SEC |
| 2026-08-21 | S, sale reported on Form 4 | 15,976 | $61.6K | 2026-08-25 | SEC |
| 2026-08-21 | S, sale reported on Form 4 | 8,411 | $32.4K | 2026-08-25 | SEC |
| 2026-08-21 | S, sale reported on Form 4 | 19,178 | $74.0K | 2026-08-25 | SEC |
FOLD
Director · 8 filings · 2 purchases and sales
Tempest Therapeutics, Inc. (TPST)
Director · 5 filings · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1321402) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
